CirTran Corporation filed its quarterly report on Form 10-Q for the period ended September 30, 2026 with the SEC on November 13, 2026, disclosing a net loss from continuing operations of $272,618 for the third quarter alongside a nine-month net income of $1,827,615 driven by discontinued operations.

Key Highlights

  • Q3 net sales: CirTran reported net sales of $663,511 for the three months ended September 30, 2026, compared to $448,492 in the same period of 2025, according to the filing.
  • Nine-month net income: The company reported net income of $1,827,615 for the nine months ended September 30, 2026, versus a net loss of $1,138,064 for the same period in 2025.
  • Continuing operations loss: Net loss from continuing operations for the nine months ended September 30, 2026 was $433,872, compared to a loss of $1,048,292 in the prior-year period.
  • Discontinued operations gain: Income from discontinued operations of $2,261,487 was recorded for the nine months ended September 30, 2026, per the filing.
  • Total stockholders' deficit: The accumulated deficit stood at $60,518,086 as of September 30, 2026, reduced from $62,345,701 at December 31, 2025.
  • Total assets: Total assets were $2,651,099 as of September 30, 2026, up from $2,514,031 at December 31, 2025.
  • Shares outstanding: As of November 13, 2026, there were 4,945,417 shares of common stock, $0.001 par value, outstanding.

CirTran Corporation's Financial Position for the Quarter Ended September 30, 2026

According to the filing, CirTran Corporation reported Q3 2026 net sales of $663,511, up from $448,492 in Q3 2025. Gross profit for the quarter was $230,196, compared to $177,826 in the year-ago quarter. Total operating expenses for the three months ended September 30, 2026 were $277,159, resulting in a loss from operations of $46,963 for the quarter. Net loss per common share, basic and diluted, was $(0.06) for the three months ended September 30, 2026.

For the nine months ended September 30, 2026, the company disclosed net sales of $2,996,530, compared to $1,077,743 in the same period of 2025. The filing attributed the nine-month net income of $1,827,615 primarily to income from discontinued operations of $2,261,487. Excluding discontinued operations, the company reported a net loss from continuing operations of $433,872 for the nine-month period. Interest expense for the nine months ended September 30, 2026 totaled $644,696, the filing stated.

As of September 30, 2026, total liabilities were $25,930,679 and total stockholders' deficit was $(23,279,580), compared to a total stockholders' deficit of $(25,107,195) at December 31, 2025. The filing disclosed accrued interest of $7,121,430, accrued payroll and compensation expense of $5,855,130, and convertible debenture, current portion net of discounts, of $2,630,917 among the current liabilities. Cash on hand increased to $130,701 as of September 30, 2026 from $9,589 at December 31, 2025. The company is incorporated in Nevada and listed no securities registered on a national exchange in its cover-page table.

What Was Disclosed

CirTran Corporation disclosed its unaudited condensed consolidated financial statements for the quarter and nine months ended September 30, 2026, showing improved net sales year over year, a nine-month net income driven by discontinued operations, and a reduced accumulated deficit compared to year-end 2025.